Fintel reports that on April 3, 2025, Canaccord Genuity initiated coverage of LifeStance Health Group (NasdaqGS:LFST) with a ...

Fintel reports that on April 3, 2025, Canaccord Genuity initiated coverage of Talkspace (NasdaqCM:TALK) with a Buy recommendation. Analyst Price Forecast Suggests 82.80% Upside As of April 2, 2025, ...

LifeSpeak (TSE:LSPK – Get Free Report) had its price target dropped by equities researchers at Canaccord Genuity Group from ...

Cantor, a premier investment bank, today announced it has entered into a definitive agreement to acquire Canaccord Genuity Group's U.S.-based wholesale market making business, which specializes in U.S ...

Canaccord Genuity analyst Katie Lachapelle maintained a Buy rating on Sigma Lithium (SGML – Research Report) today and set a price target of ...

Canaccord Genuity has established itself as a market leader in M&A advisory and equity capital markets across the technology, healthcare, sustainability, and consumer sectors. The Company's global ...

To join the virtual panel discussion, please contact your Canaccord Genuity conference representative. About Marker Therapeutics, Inc. Marker Therapeutics, Inc. is a Houston, TX-based clinical ...

Canaccord Genuity Group said Tuesday that it agreed to sell its U.S. wholesale market-making business as it looks to focus more on its investment-banking platform. The Toronto financial-services firm ...

Canaccord Genuity Group restated their speculative buy rating on shares of Spirent Communications (LON:SPT – Free Report) in ...

This week’s episode features Canaccord Genuity senior investment advisor Cam Currie in conversation with host Adrian Pocobelli on the outlook for gold stocks. Currie shares his insights on gold and ...

Analysts at Canaccord Genuity initiated coverage on transportation and logistics industry software provider Microlise at 'buy ...

Marker Therapeutics is advancing a unique multi antigen recognizing (MAR)-T cell therapy platform designed to target multiple tumor-associated antigens simultaneously, an approach that has shown ...